176
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Fabrication and analysis of chitosan oligosaccharide based mucoadhesive patch for oromucosal drug delivery

ORCID Icon, , , & ORCID Icon
Pages 602-610 | Received 24 Sep 2021, Accepted 29 Oct 2022, Published online: 17 Nov 2022

References

  • Morales JO, Brayden DJ. Buccal delivery of small molecules and biologics: of mucoadhesive polymers, films, and nanoparticles. Curr Opin Pharmacol. 2017;36:22–28.
  • Schiele JT, Quinzler R, Klimm HD, et al. Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms. Eur J Clin Pharmacol. 2013;69(4):937–948.
  • Stegemann S, Gosch M, Breitkreutz J. Swallowing dysfunction and dysphagia is an unrecognized challenge for oral drug therapy. Int J Pharm. 2012;430(1–2):197–206.
  • Schiele JT, Penner H, Schneider H, et al. Swallowing tablets and capsules increases the risk of penetration and aspiration in patients with stroke-induced dysphagia. Dysphagia. 2015;30(5):571–582.
  • Desai K, Warade AC, Jha AK, et al. Injection-related iatrogenic peripheral nerve injuries: surgical experience of 354 operated cases. Neurol India. 2019;67(Supplement):S82–S91.
  • Kim HJ, Park SK, Park SH. Upper limb nerve injuries caused by intramuscular injection or routine venipuncture. Anesth Pain Med. 2017;12(2):103–110.
  • Park CW, Cho WC, Son BC. Iatrogenic injury to the sciatic nerve due to intramuscular injection: a case report. Korean J Neurotrauma. 2019;15(1):61–66.
  • Morales JO, McConville JT. Novel strategies for the buccal delivery of macromolecules. Drug Dev Ind Pharm. 2014;40(5):579–590.
  • Smart J, Keegan G. Buccal drug delivery systems. In: Wen H, Park K, editors. Oral controlled release formulation design and drug delivery: theory to practice. New Jersey: john Wiley & Sons; 2010. pp. 169–184.
  • Rossi S, Sandri G, Caramella CM. Buccal drug delivery: a challenge already won? Drug Discov Today Technol. 2005;2(1):59–65.
  • Kumar A, Vimal A, Kumar A. Why chitosan? From properties to perspective of mucosal drug delivery. Int J Biol Macromol. 2016;91:615–622.
  • Szymańska E, Winnicka K. Stability of chitosan-a challenge for pharmaceutical and biomedical applications. Mar Drugs. 2015;13(4):1819–1846.
  • Zargar V, Asghari M, Dashti A. A review on chitin and chitosan polymers: structure, chemistry, solubility, derivatives, and applications. ChemBioEng Rev. 2015;2(3):204–226.
  • Liang S, Sun Y, Dai X. A review of the preparation, analysis and biological functions of chitooligosaccharide. Int J Mol Sci. 2018;19(8):2197.
  • MacLaughlin FC, Mumper RJ, Wang J, et al. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J Control Release. 1998;56(1–3):259–272.
  • Richardson SC, Kolbe HV, Duncan R. Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int J Pharm. 1999;178(2):231–243.
  • Colonna C, Genta I, Perugini P, et al. 5-methyl-pyrrolidinone chitosan films as carriers for buccal administration of proteins. AAPS PharmSciTech. 2006;7(3):70.
  • Chinwala MG, Lin S. Application of hydrogel polymers for development of thyrotropin releasing hormone-loaded adhesive buccal patches. Pharm Dev Technol. 2010;15(3):311–327.
  • Rossi S, Sandri G, Ferrari F, et al. Buccal delivery of acyclovir from films based on chitosan and polyacrylic acid. Pharm Dev Technol. 2003;8(2):199–208.
  • Davoudi Z, Rabiee M, Houshmand B, et al. Development of chitosan/gelatin/keratin composite containing hydrocortisone sodium succinate as a buccal mucoadhesive patch to treat desquamative gingivitis. Drug Dev Ind Pharm. 2018;44(1):40–55.
  • Mašek J, Lubasová D, Lukáč R, et al. Multi-layered nanofibrous mucoadhesive films for buccal and sublingual administration of drug-delivery and vaccination nanoparticles – important step towards effective mucosal vaccines. J Control Release. 2017;249:183–195.
  • Ryu JH, Choi JS, Park E, et al. Chitosan oral patches inspired by mussel adhesion. J Control Release. 2020;317:57–66.
  • Kumar A, Kumar A. Fabrication of eggshell membrane– based novel buccal mucosa–mimetic surface andmucoadhesion testing of chitosan oligosaccharide film. J Mater Res. 2019;34(22):3777–3786.
  • Shojaei AH, Khan M, Lim G, et al. Transbuccal permeation of a nucleoside analog, dideoxycytidine: effects of menthol as a permeation enhancer. Int J Pharm. 1999;192(2):139–146.
  • Chen J, Jiang QD, Chai YP, et al. Natural terpenes as penetration enhancers for transdermal drug delivery. Molecules. 2016;21(12):1709.
  • Cheung RC, Ng TB, Wong JH, et al. Chitosan: an update on potential biomedical and pharmaceutical applications. Mar Drugs. 2015;13(8):5156–5186.
  • Azuma K, Osaki T, Minami S, et al. Anticancer and anti-inflammatory properties of chitin and chitosan oligosaccharides. J Funct Biomater. 2015;6(1):33–49.
  • Gal JY, Fovet Y, Adib-Yadzi M. About a synthetic saliva for in vitro studies. Talanta. 2001;53(6):1103–1115.
  • Jameela SR, Kumary TV, Lal AV, et al. Progesterone-loaded chitosan microspheres: a long acting biodegradable controlled delivery system. J Control Release. 1998;52(1–2):17–24.
  • Dash S, Murthy PN, Nath L, et al. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 2010;67(3):217–223.
  • Siepmann J, Peppas NA. Higuchi equation: derivation, applications, use and misuse. Int J Pharm. 2011;418(1):6–12.
  • Thirion-Delalande C, Gervais F, Fisch C, et al. Comparative analysis of the oral mucosae from rodents and non-rodents: application to the nonclinical evaluation of sublingual immunotherapy products. PLoS One. 2017;12(9):e0183398.
  • Pereira GR, Marchetti JM, Bentley MVLB. A rapid method for determination of progesterone by reversed-phase liquid chromatography from aqueous media. Anal. Lett. 2000;33(5):881–889.
  • Nazıroğlu M, Blum W, Jósvay K, et al. Menthol evokes Ca2+ signals and induces oxidative stress independently of the presence of TRPM8 (menthol) receptor in cancer cells. Redox Biol. 2018;14:439–449.
  • Nagai K, Fukuno S, Omachi A, et al. Enhanced anti-cancer activity by menthol in HepG2 cells exposed to paclitaxel and vincristine: possible involvement of CYP3A4 downregulation. Drug Metab Pers Ther. 2019;34(1):29.
  • Carpenter GH. The secretion, components, and properties of Saliva. Annu Rev Food Sci Technol. 2013;4(1):267–276.
  • Madsen KD, Sander C, Baldursdottir S, et al. Development of an ex vivo retention model simulating bioadhesion in the oral cavity using human saliva and physiologically relevant irrigation media. Int J Pharm. 2013;448(2):373–381.
  • Gittings S, Turnbull N, Henry B, et al. Characterisation of human saliva as a platform for oral dissolution medium development. Eur J Pharm Biopharm. 2015;91:16–24.
  • Yildiz Pekoz A, Sedef Erdal M, Okyar A, et al. Preparation and in-vivo evaluation of dimenhydrinate buccal mucoadhesive films with enhanced bioavailability. Drug Dev Ind Pharm. 2016;42(6):916–925.
  • Kumar A, Kumar A. The virtuous potential of chitosan oligosaccharide for promising biomedical applications. J Mater Res. 2020;35(9):1123–1134.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.